-
srdr.ahrq.gov/projects/1709/studies/197262
January 01, 2020 - Key Questions Addressed
9
Medication management KQ 1: What are the characteristics of interventions … Comments ( 0 ) |
Post/View
10
Medication management KQ 2: What … Comments ( 0 ) |
Post/View
11
Medication management KQ 3: What … Comments ( 0 ) |
Post/View
12
Medication management KQ 4: What … Extraction Form: Medication Management
Arms
No arms have been defined in this extraction
-
srdr.ahrq.gov/projects/1709/studies/197263
January 01, 2019 - Key Questions Addressed
9
Medication management KQ 1: What are the characteristics of interventions … Comments ( 0 ) |
Post/View
10
Medication management KQ 2: What … Comments ( 0 ) |
Post/View
11
Medication management KQ 3: What … Comments ( 0 ) |
Post/View
12
Medication management KQ 4: What … Extraction Form: Medication Management
Arms
No arms have been defined in this extraction
-
srdr.ahrq.gov/projects/1671/studies/196205
January 01, 2020 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196130
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196134
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196160
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196146
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196170
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196098
January 01, 2020 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196129
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196111
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196119
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196182
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196168
January 01, 2019 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196118
January 01, 2001 - Title and Description
Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy? … Title Data
Title
Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication
-
srdr.ahrq.gov/projects/1709/studies/197264
January 01, 2013 - Key Questions Addressed
9
Medication management KQ 1: What are the characteristics of interventions … Comments ( 0 ) |
Post/View
10
Medication management KQ 2: What … Comments ( 0 ) |
Post/View
11
Medication management KQ 3: What … Comments ( 0 ) |
Post/View
12
Medication management KQ 4: What … Extraction Form: Medication Management
Arms
No arms have been defined in this extraction
-
srdr.ahrq.gov/projects/1671/studies/196176
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196180
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196158
January 01, 2006 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196167
January 01, 2005 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?